ConductScience.org, home

Paper422302

Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine.

Welling PG and 3 others. Int J Clin Pharmacol Biopharm, 1979. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine. Papers, record 422302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422302

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine.
PubMed
Journal
Int J Clin Pharmacol Biopharm
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2015-11-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Welling PGP G
2Thomsen JHJ H
3Shug ALA L
4Tse FLF L

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarnitineMajor topic
Adult
Aged
Humans
Infusions, Parenteral
Kinetics
Male
Middle Aged
Stereoisomerism
Time Factors

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
12948009L-carnitine transport in kidney of normotensive, Wistar-Kyoto rats: effect of chronic L-carnitine administration.Pharm Res2003https://conductscience.org/library/papers/12948009PubMed
12908852Pharmacokinetics of L-carnitine.Clin Pharmacokinet2003https://conductscience.org/library/papers/12908852PubMed
6733367
Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function.
Br J Pharmacol1984https://conductscience.org/library/papers/6733367PubMed
3383994Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3383994PubMed
3308409
l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.
Drugs1987https://conductscience.org/library/papers/3308409PubMed
3234464Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3234464PubMed
3220097Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3220097PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/422302

GET https://conductscience.org/api/papers/v1/422302/authors